Financhill
Buy
63

MRUS Quote, Financials, Valuation and Earnings

Last price:
$96.92
Seasonality move :
11.04%
Day range:
$96.91 - $96.96
52-week range:
$33.19 - $97.14
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
121.82x
P/B ratio:
9.48x
Volume:
193.8K
Avg. volume:
1.2M
1-year change:
128.51%
Market cap:
$7.4B
Revenue:
$36.1M
EPS (TTM):
-$5.33

Earnings Data

Next earnings date for MRUS
Feb 26
2026
Most recent earnings per share
-$1.26
Beat by $0.10
(Nov 12/2025)
Consensus Estimate
-$1.36
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRUS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $8.5M -- -- -$1.06 --
11/12/2025 Q3 $8.7M $12.2M -$1.26 -$1.36 $0.10
08/05/2025 Q2 $9.8M $8.8M -$2.23 -$1.15 -$1.07
05/07/2025 Q1 $7.2M $26.5M -$1.40 -$1.06 -$0.33
02/27/2025 Q4 $10.6M $9.1M -$0.45 -$0.90 $0.45
10/31/2024 Q3 $8.7M $11.8M -$1.46 -$0.85 -$0.62
08/01/2024 Q2 $8.4M $7.3M -$0.81 -$0.75 -$0.06
05/08/2024 Q1 $8.7M $7.9M -$0.59 -$0.80 $0.21
02/28/2024 Q4 $10.1M $8.9M -$1.04 -$0.71 -$0.33
11/02/2023 Q3 -- $11M -$0.43 -- --
08/07/2023 Q2 -- $10.5M -$0.66 -- --
05/04/2023 Q1 -- $13.5M -$0.86 -- --
02/28/2023 Q4 -- $10.7M -$1.77 -- --
11/03/2022 Q3 -- $6.6M -$0.53 -- --
08/08/2022 Q2 -- $12.7M -$0.13 -- --
05/09/2022 Q1 -- $11.7M -$0.43 -- --
03/16/2022 Q4 -- $14.7M -$0.34 -- --
11/02/2021 Q3 -- $13.7M -$0.39 -- --
08/05/2021 Q2 -- $12.4M -$0.71 -- --
05/06/2021 Q1 -- $8.4M -$0.28 -- --
03/16/2021 Q4 -- $9M -$0.94 -- --
11/05/2020 Q3 -- $8.6M -$0.79 -- --
08/06/2020 Q2 -- $6.1M -$0.62 -- --
05/11/2020 Q1 -- $6.3M -$0.57 -- --
03/12/2020 Q4 -- -- -- -- --
12/12/2019 Q3 -- $8.2M -$0.40 -- --
08/19/2019 Q2 -- $6.4M -$0.57 -- --
04/03/2019 Q1 -- $8.8M -$0.30 -- --
12/31/2018 Q4 -- $9.7M -$0.03 -- --
12/27/2018 Q3 -- $7.6M -$0.55 -- --
07/26/2018 Q2 -- $7.7M -$0.24 -- --
04/26/2018 Q1 -- $12.1M -$0.49 -- --
12/31/2017 Q4 -- $6.7M -$0.73 -- --
11/30/2017 Q3 -- $6.7M -$0.81 -- --
07/11/2017 Q2 -- $6M -$1.11 -- --
04/28/2017 Q1 -- $4.1M -$1.13 -- --
12/31/2016 Q4 -- $1.2M -$2.06 -- --
09/30/2016 Q3 -- $995.6K -$0.35 -- --
06/30/2016 Q2 -- $216.8K -$0.34 -- --
03/31/2016 Q1 -- $61.7K -$0.69 -- --
12/31/2015 Q4 -- $62.4K -$0.45 -- --

Merus NV Earnings Questions

  • How Much did Merus NV Generate in Revenue Last Quarter?

    Merus NV reported $12.2M worth of top line sales in its most recent quarter.

  • Did Merus NV Beat Earnings Last Quarter?

    Merus NV announced earnings per share of -$1.26 which represents a beat of analyst forecast a -$1.36 per share.

  • Is Merus NV Profitable?

    Merus NV reported $11.5M that represents $0.15 per share over the last quarter.

  • What is the Analyst Consensus for Merus NV EPS Next Year?

    Merus NV's earnings are forecast to decrease from -$3.35 per share to -$3.72 per share next year representing a decrease of -69.52%.

  • When is Merus NV's Earnings Date?

    Merus NV's next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock